sever
acut
respiratori
syndrom
sar
caus
novel
coronaviru
sarscov
futur
research
molecular
virolog
sarscov
import
understand
epidemiolog
natur
histori
sar
also
facilit
develop
sensit
accur
diagnost
test
well
vaccin
therapeut
combat
sar
novemb
outbreak
lifethreaten
atyp
pneumonia
etiolog
agent
could
identifi
occur
guangdong
provinc
china
march
similar
outbreak
report
hong
kong
case
similar
respiratori
ill
subsequ
report
global
includ
china
taiwan
singapor
vietnam
canada
usa
syndrom
new
clinic
entiti
design
sever
acut
respiratori
syndrom
sar
time
write
world
health
organ
report
case
death
countri
result
sar
see
http
vigor
research
carri
worldwid
understand
caus
possibl
prevent
measur
diseas
believ
caus
highli
contagi
viru
less
four
week
global
outbreak
novel
coronaviru
sarscoronaviru
sarscov
identifi
blood
respiratori
specimen
oropharyng
wash
nasopharyng
aspir
sputum
lung
biopsi
stool
sar
patient
variou
research
group
typic
coronaviru
particl
nm
diamet
nm
complex
surfac
project
surround
peripheri
seen
electron
microscopi
direct
cytopath
effect
could
demonstr
inocul
viral
isol
african
green
monkey
kidney
vero
cell
indic
pathogen
properti
novel
coronaviru
compar
nucleotid
sequenc
limit
region
sarscov
genom
found
differ
human
anim
coronavirus
recent
sequenc
entir
genom
mani
sarscov
strain
complet
singlestrand
plussens
rna
viru
kb
length
genom
sequenc
close
resembl
previous
character
coronavirus
data
support
etiolog
role
novel
coronaviru
pathogenesi
sar
sarscov
genom
contain
open
read
frame
code
replicas
four
major
structur
protein
nucleocapsid
n
envelop
e
membran
spike
sever
protein
unknown
function
replicas
cleav
form
mani
protein
includ
viral
proteas
rnadepend
rna
polymeras
rna
helicas
rnadepend
rna
polymeras
errorpron
polymeras
therefor
high
mutat
recombin
rate
coronaviru
genom
expect
nproxim
cproxim
region
replicas
process
papainlik
proteas
respect
recent
crystal
structur
human
coronaviru
hcov
pro
determin
sarscov
pro
display
amino
acid
sequenc
ident
hcov
pro
threedimension
model
sarscov
pro
construct
bioinformat
model
use
basi
design
antivir
inhibitor
pro
n
protein
bind
viral
rna
form
helic
nucleocapsid
interior
caviti
sarscov
virion
wherea
e
protein
import
assembl
viral
envelop
protein
membran
glycoprotein
promin
petalshap
spike
surfac
virion
glycoprotein
import
viral
entri
might
defin
host
rang
tissu
tropism
virul
mutat
protein
gene
previous
correl
alter
pathogenesi
virul
coronavirus
although
carcinoembryon
antigen
celladhes
molecul
aminopeptidas
n
identifi
receptor
coronavirus
human
receptor
sarscov
still
remain
elucid
studi
variat
mutat
spike
glycoprotein
gene
could
add
clue
understand
biolog
pathogenesi
novel
sarscov
origin
sarscov
certain
possibl
zoonos
exclud
epidemiolog
studi
demonstr
human
transmiss
close
person
person
contact
healthcar
worker
household
contact
highest
risk
droplet
formit
believ
major
rout
transmiss
although
guangdong
provinc
china
public
sourc
global
sar
outbreak
new
case
epidemiolog
traceabl
sar
patient
china
report
variou
part
world
studi
epidemiolog
origin
relationship
differ
sar
patient
compar
genom
sequenc
analysi
sarscov
isol
perform
total
sequenc
variat
recurr
variant
sequenc
identifi
common
variant
sequenc
defin
two
distinct
genotyp
sarscov
one
link
infect
origin
hotel
hong
kong
anoth
isol
hong
kong
guangzhou
beij
associ
hotel
mutat
arisen
particular
gener
appear
follow
gener
recurr
sequenc
polymorph
might
serv
genet
signatur
trace
contact
sourc
sarscov
forthcom
task
would
investig
possibl
effect
sequenc
variat
infect
tissu
tropism
pathogen
viru
natur
histori
sar
relat
viral
dynam
sarscov
poorli
understood
sar
primarili
respiratori
diseas
highest
concentr
viru
found
respiratori
tract
febril
phase
logic
infect
respiratori
secret
febril
stage
high
infect
incub
period
rang
day
fever
occur
uncertain
patient
fever
settl
within
two
week
accompani
resolut
chest
symptom
radiolog
chang
howev
sarscov
still
found
stool
sampl
polymeras
chain
reaction
pcr
two
week
convalesc
indic
delay
fecal
viral
shed
potenti
fecalor
rout
transmiss
droplet
sarscovcontamin
sewag
soil
stack
extract
bathroom
exhaust
fan
might
respons
outbreak
sar
among
resid
amoy
garden
hong
kong
see
hong
kong
depart
health
report
outbreak
sever
acut
respiratori
syndrom
sar
amoy
garden
kowloon
bay
hong
kong
main
find
investig
http
wwwinfogovhkdhaphtm
understand
viral
load
infect
differ
stage
sar
quantif
serial
viral
titer
realtim
pcr
studi
viral
dynam
blood
respiratori
secret
excreta
requir
inform
import
implement
public
health
measur
prevent
spread
sar
commun
current
diagnosi
sar
base
clinic
featur
radiolog
find
histori
sar
contact
see
report
case
definit
surveil
sar
http
wwwwhointcsrsarscaedefinitionen
often
inconclus
particularli
earli
stage
diseas
among
elderli
patient
nonspecif
symptom
asymptomat
patient
incub
phase
also
overlook
current
day
quarantin
travel
area
sar
outbreak
practic
mani
countri
caus
major
inconveni
econom
loss
therefor
sensit
accur
laboratori
diagnost
test
urgent
requir
pcrbase
test
use
sarscovspecif
primer
achiev
good
specif
therefor
use
confirmatori
test
see
report
laboratori
diagnost
test
sar
http
www
whointcsrsarsdiagnostictestsen
unfortun
high
falseneg
rate
might
relat
low
viral
load
particular
site
time
sampl
collect
possibl
genom
variat
differ
sarscov
strain
limit
use
test
diagnost
tool
appropri
select
sampl
site
differ
phase
diseas
use
primer
wellconserv
region
differ
sarscov
variant
form
basi
develop
accur
diagnost
test
avail
reliabl
screen
test
use
detect
sar
incub
phase
among
asymptomat
close
contact
index
patient
serolog
assay
altern
diagnosi
sar
antibodi
titer
usual
low
incub
phase
initi
phase
ill
convalesc
antibodi
titer
might
sometim
necessari
confirm
diagnosi
vaccin
one
solut
control
sar
immunolog
target
could
spike
glycoprotein
defin
viru
host
interact
predict
amino
acid
sequenc
spike
glycoprotein
sarscov
low
level
similar
coronavirus
like
sarscov
differ
receptorbind
specif
antigen
properti
research
antigen
differ
motif
spike
glycoprotein
among
differ
strain
sarscov
import
human
coronaviru
infect
reinfect
common
owe
presenc
multipl
antigen
coronaviru
strain
mutat
could
affect
antigen
properti
viru
protect
vaccin
develop
besid
vaccin
sever
approach
might
consid
treat
sar
patient
futur
proteas
rna
polymeras
potenti
target
develop
antivir
drug
decreas
rate
viru
propag
antibodi
protein
receptor
might
neutral
viru
block
viral
entri
synthet
peptid
might
also
block
cell
fusion
viral
entri
case
treatment
hiv
type
infect
conclus
combat
dread
diseas
better
understand
molecular
biolog
sarscov
essenti
applic
knowledg
aid
futur
diagnosi
manag
prevent
sar
sever
acut
respiratori
syndrom
sar
emerg
late
southern
china
rapidli
spread
countri
around
globe
three
research
group
within
world
health
organ
coordin
network
independ
simultan
shown
novel
coronaviru
link
sar
fourth
group
complet
koch
postul
infect
monkey
agent
sequenc
complet
genom
achiev
week
first
isol
viru
becam
avail
diseas
involv
initi
febril
phase
follow
interstiti
pneumonia
lead
respiratori
distress
syndrom
death
fraction
patient
cumul
case
fatal
rate
time
write
basi
gammadistribut
model
number
recent
correct
valu
patient
year
age
becam
clear
midmarch
hospit
outbreak
high
rate
transmiss
simultan
occur
hanoi
singapor
hong
kong
toronto
canada
issu
global
health
alert
initi
studi
network
laboratori
dedic
clarifi
etiolog
sar
four
recent
articl
describ
member
network
rapidli
identifi
confirm
novel
coronaviru
caus
agent
independ
yet
collabor
manner
begin
investig
known
caus
agent
interstiti
pneumonia
sought
patient
differ
site
outbreak
anecdot
result
laboratori
point
involv
chlamydia
rhinovirus
paramyxovirus
howev
laboratori
could
confirm
presenc
pathogen
cohort
patient
initi
experiment
step
three
group
later
succeed
identifi
caus
pathogen
inocul
variou
cell
cultur
line
patient
specimen
wherea
cell
commonli
use
respiratori
pathogen
eg
rde
hela
mdck
yield
indic
result
viru
could
replic
monkey
kidney
cell
group
hong
kong
first
observ
cytopath
effect
compat
viral
growth
day
inocul
lung
biopsi
specimen
nasopharyng
aspir
sampl
fetal
rhesu
kidney
cell
cytopath
effect
consist
cell
round
detach
specif
immun
respons
correspond
author
christian
drosten
drosten
bnihamburgd
